CSR & 3D Printing: driving sustainable innovation in medtech
At MB Therapeutics, a pharmaceutical company specializing in 3D printing,Corporate Social Responsibility (CSR) is not an option, but a strategic choice. Since our inception, we have chosen to combine technological innovation with environmental commitment to contribute to a more sustainable future.
What is Corporate Social Responsibility?
CSR refers to the set of practices implemented by a company to uphold the principles of sustainable development. This includes:
- Reducing environmental impact.
- Respecting human rights and the well-being of employees.
- Engaging in societal initiatives beyond the pursuit of profit.
In the healthcare sector, CSR-related challenges are particularly significant. Traceability, safety, eco-design… integrating CSR from the outset ensures sustainable growth, aligned with the challenges of tomorrow.
Why is CSR strategic for a medtech company?
In the pharmaceutical and technology sector, adopting a CSR approach has become essential. Indeed, this initiative helps strengthen the company’s credibility and societal acceptance, which are key elements for ensuring long-term success.
For MB Therapeutics, integrating CSR into its strategy is a way to build trust with partners and investors. It demonstrates a genuine commitment to sustainable development and social responsibility.
Moreover, this approach also helps attract and retain talent. New generations of employees are increasingly sensitive to the social and environmental impact of the companies they work for. A company culture focused on CSR becomes a key factor in attracting motivated and engaged profiles.
Beyond these benefits, CSR helps reduce long-term costs. More efficient resource management, risk prevention, and process optimization enable the company to better control its expenses while contributing to the reduction of its ecological footprint.
How does MB Therapeutics integrate CSR into its strategy?
At MB Therapeutics, CSR is not just about theoretical commitments. We have implemented concrete actions that align with a long-term approach, combining innovation, sustainability, and responsibility.
1. Responsible production through 3D printing
As a company specializing in 3D printing, we use this technology to manufacture customized medical devices. This method offers several advantages:
- On-demand production: By producing only what is needed, we avoid overproduction and waste, contributing to more efficient resource management.
- Waste reduction: Thanks to the precision of 3D printing, we save up material on certain prototypes, thus reducing our environmental footprint.
- Local and national manufacturing: This approach allows us to limit transportation and logistical impact, thus promoting sustainable production.
2. Offices designed according to circular economy principles
We have also rethought the design of our offices to make them both functional and environmentally friendly. In collaboration with Les Simones, a duo of interior designers specializing in second-hand furniture, we chose to reuse furniture to furnish our workspace. This project has allowed us to:
- Reduce the carbon impact of furniture by opting for recycled materials.
- Give a second life to professional furniture, rather than buying new items.
- Support a local and responsible initiative.
Thus, our offices have become a true reflection of our values: aesthetic, functional, and responsible.
Conclusion
At MB Therapeutics, we believe that it is possible to reconcile innovation and responsibility. CSR is an integral part of our strategy, and we are convinced that this approach is not only beneficial for the planet but also for the sustainable growth of our company.
Our ambition is to demonstrate that it is possible to be a high-performing, agile, and responsible biotech company.
